Maturing antibody-drug conjugate pipeline hits 30

Nat Rev Drug Discov. 2013 May;12(5):329-32. doi: 10.1038/nrd4009.
No abstract available

MeSH terms

  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / therapeutic use
  • Chemistry, Pharmaceutical
  • Drug Discovery / trends*
  • Hematologic Neoplasms / drug therapy
  • Humans
  • Immunoconjugates / administration & dosage
  • Immunoconjugates / therapeutic use*
  • Neoplasms / drug therapy

Substances

  • Antineoplastic Agents
  • Immunoconjugates